155 related articles for article (PubMed ID: 37565313)
1. Cytoplasmic SIRT1 promotes paclitaxel resistance in ovarian carcinoma through increased formation and survival of polyploid giant cancer cells.
Xu H; Zeng S; Wang Y; Yang T; Wang M; Li X; He Y; Peng X; Li X; Qiao Q; Zhang J
J Pathol; 2023 Oct; 261(2):210-226. PubMed ID: 37565313
[TBL] [Abstract][Full Text] [Related]
2. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs).
Bowers RR; Andrade MF; Jones CM; White-Gilbertson S; Voelkel-Johnson C; Delaney JR
BMC Cancer; 2022 Apr; 22(1):410. PubMed ID: 35421971
[TBL] [Abstract][Full Text] [Related]
3. Linking unfolded protein response to ovarian cancer cell fusion.
Yart L; Bastida-Ruiz D; Allard M; Dietrich PY; Petignat P; Cohen M
BMC Cancer; 2022 Jun; 22(1):622. PubMed ID: 35672715
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma.
Yang T; Zhou R; Yu S; Yu S; Cui Z; Hu P; Liu J; Qiao Q; Zhang J
Mol Cell Biochem; 2019 Sep; 459(1-2):157-169. PubMed ID: 31317367
[TBL] [Abstract][Full Text] [Related]
5. Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.
Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S
J Exp Clin Cancer Res; 2020 May; 39(1):83. PubMed ID: 32393310
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
Niu N; Mercado-Uribe I; Liu J
Oncogene; 2017 Aug; 36(34):4887-4900. PubMed ID: 28436947
[TBL] [Abstract][Full Text] [Related]
7. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development.
Zhang S; Mercado-Uribe I; Hanash S; Liu J
PLoS One; 2013; 8(11):e80120. PubMed ID: 24348907
[TBL] [Abstract][Full Text] [Related]
8. Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer.
Zhang X; Yao J; Li X; Niu N; Liu Y; Hajek RA; Peng G; Westin S; Sood AK; Liu J
Sci Adv; 2023 Jul; 9(29):eadf7195. PubMed ID: 37478190
[TBL] [Abstract][Full Text] [Related]
9. The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance.
Fei F; Qu J; Liu K; Li C; Wang X; Li Y; Zhang S
Lab Invest; 2019 Apr; 99(4):483-498. PubMed ID: 30487595
[TBL] [Abstract][Full Text] [Related]
10. [Autophagy promotes recurrence of nasopharyngeal carcinoma via inducing the formation of dormant polyploid giant cancer cells].
Xia T; Ji Y; Lu YN; Xie HJ; You YW; You B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1102-1109. PubMed ID: 36177565
[No Abstract] [Full Text] [Related]
11. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.
Liu K; Lu R; Zhao Q; Du J; Li Y; Zheng M; Zhang S
Med Oncol; 2019 Nov; 37(1):6. PubMed ID: 31734829
[TBL] [Abstract][Full Text] [Related]
12. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel.
Zhang S; Mercado-Uribe I; Liu J
Int J Cancer; 2014 Feb; 134(3):508-18. PubMed ID: 23754740
[TBL] [Abstract][Full Text] [Related]
13. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
14. IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming.
Niu N; Yao J; Bast RC; Sood AK; Liu J
Oncogenesis; 2021 Sep; 10(9):65. PubMed ID: 34588424
[TBL] [Abstract][Full Text] [Related]
15. Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.
Saini G; Joshi S; Garlapati C; Li H; Kong J; Krishnamurthy J; Reid MD; Aneja R
Semin Cancer Biol; 2022 Jun; 81():220-231. PubMed ID: 33766651
[TBL] [Abstract][Full Text] [Related]
16. Polyploid giant cancer cells and ovarian cancer: new insights into mitotic regulators and polyploidy†.
Richards JS; Candelaria NR; Lanz RB
Biol Reprod; 2021 Aug; 105(2):305-316. PubMed ID: 34037700
[TBL] [Abstract][Full Text] [Related]
17. IL-1β is involved in docetaxel chemoresistance by regulating the formation of polyploid giant cancer cells in non-small cell lung cancer.
Zhao S; Xing S; Wang L; Ouyang M; Liu S; Sun L; Yu H
Sci Rep; 2023 Aug; 13(1):12763. PubMed ID: 37550397
[TBL] [Abstract][Full Text] [Related]
18. Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.
Lv H; Shi Y; Zhang L; Zhang D; Liu G; Yang Z; Li Y; Fei F; Zhang S
BMC Cancer; 2014 Aug; 14():576. PubMed ID: 25106448
[TBL] [Abstract][Full Text] [Related]
19. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.
Zhang S; Mercado-Uribe I; Xing Z; Sun B; Kuang J; Liu J
Oncogene; 2014 Jan; 33(1):116-28. PubMed ID: 23524583
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid targets chemo-resistant polyploid giant cancer cells.
Adibi R; Moein S; Gheisari Y
Sci Rep; 2023 Jan; 13(1):419. PubMed ID: 36624105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
